|
EBS Emergent Biosolutions Inc 1367644 |
| Balance Sheet |
|
Current Assets
|
$637,600,000.00 |
|
Assets
|
$1,320,400,000.00 |
|
Current Liabilities
|
$148,700,000.00 |
|
Liabilities
|
$797,300,000.00 |
|
Equity
|
$523,100,000.00 |
|
Shares Out
|
51800000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-33,800,000.00 |
|
Investing Cash Flow
|
$-2,400,000.00 |
| Market Analysis |
Market Cap
|
$376,068,000.00 |
|
Price
|
$7.28 |
|
BVPS
|
10.10 |
|
PB
|
0.72 |
|
EPS
|
0.13 |
|
PS
|
0.69 |
|
FCF
|
$-36,200,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:27 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.43 |
|
| Apr |
May |
Jun |
|
|
2026-04-30 |
0.21 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.16 |
|
| Oct |
Nov |
Dec |
|
|
2025-10-29 |
1.06 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EBS documents filed with the SEC.
EBS Filings
Clear
